Pending Failure in Hard-hard Total Hip Arthroplasty
PF
Early Diagnosis of Pending Failures of Total Hip Arthroplasty With Hard to Hard Bearings
1 other identifier
observational
148
1 country
1
Brief Summary
During last 6 years approximately 10.000 ceramic balls and 5.000 ceramic liners have been implanted in the region Emilia-Romagna in Italy (4 million Every single year approximately 60.000 hip prostheses are implanted in Italy. Quality of life of patients after surgery is very good, as widely demonstrated in the literature. On the basis of data produced by the only complete hip register in Italy that is run in our Lab (RIPO, Register of Orthopedic Implants in the Region Emilia-Romagna) survival rate of primary total hip prosthesis is 95.6% at 9 years. Reasons for revision are mainly aseptic loosening of one or both components (40% of the total) and dislocation (26%), being the latter much more frequent in the first two years. Less frequently revision is due to sepsis (7% of the total),bone fracture (11%), prosthesis fracture (3%) or pain (3%). Revision is relates, among the others, to prosthesis-related factors, such as fixation to bone and articular coupling. In our experience, during the last ten years 32% of implants had both articular component in ceramic , 34% had metal head and plastic liner, 24% ceramic head and plastic liner, 10% both components in metal. Each solution has strengths and weakness and they have been identified and clinically applied in order to overcome step by step limitations observed in the previous one. The most recent are the hard-on-hard bearings, that is ceramic on ceramic and metal on metal. These two solutions, beside very promising results on wear resistance, show some peculiar failures: respectively fracture of the ceramic component and hypersensitivity induced by metal ions. Aim of research proposal is to investigate two uncommon and less investigated early symptoms of failure:
- 'noising hip' in ceramic on ceramic total hip arthroplasty
- pain without radiographic signs of loosening in metal on metal total hip arthroplasty These two situations are extremely relevant, as they prelude to a failure of the prosthesis. If clearly identified they could represent a powerful tool in early diagnosis of pending failure To reach this goal our patients wearing hard-on-hard total hip arthroplasty, suffering for described symptoms will undergone a specific diagnostic procedure. The first group will be studied through CT scan of the patients to evaluate impingement or instability of the prosthesis, and a needle aspiration for synovial fluid. The fluid will be examined to identify ceramic wear debris, according to a method of separation and analysis in scanning electron microscopy that was set in our Lab. Sound will be recorded by means of a wearable sensor set capable of recording the articular noise produced during level walking. This instrumentation will be coupled to motion analysis technology. This would make possible a diagnostic approach able to correlate the involved factors to clinical occurrences, on the basis of the recorded frequencies.
- Second group will be studied through the dosage of circulating ions, deriving from the articular surfaces and through the histological classification of vasculitis in periimplant tissues. There is increasing evidence, indeed that locale release of submicron particles worn out from articular surfaces can release metal ions (mainly Chromium and Cobalt) responsible for lymphocyte local infiltration. In particular CD20 positive B lymphocyte and CD3 positive T lymphocyte and sometimes CD68 positive plasma cells are present. The cells could justify the development of pseudotumors in metal-on metal hip prosthesis. Data collected from patients matched to in vitro results will allow us to to avoid or at least propose a more appropriate timing for revision surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2012
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 19, 2015
CompletedFirst Posted
Study publicly available on registry
April 28, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2016
CompletedResults Posted
Study results publicly available
May 25, 2016
CompletedMay 25, 2016
April 1, 2016
3.5 years
February 19, 2015
February 8, 2016
April 18, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Number of Participants With Chromium and Cobalt Ion Levels Above 7ug/l
Measured by Inductively coupled plasma mass spectrometry (ICP-MS), equipped with dynamic cell reaction (ELAN DRC II) and expressed in micrograms/liter. Will be counted the number of patients with level os metals above 7micrograms/liter This outcome is valuable only for MoM arm and Control arm (as comparison), because CoC arm patients don't wear device releasing this kind of metals.
3 years
Duration of Articular Noise Produced During Level Walking
Measured by fast Fourier transform (FFT) expressed in duration (milliseconds) This outcome is valuable only for CoC arm and MoM arm, because Control arm patients don't wear prosthesis (no noise)
3 years
Frequency of Articular Noise Produced During Level Walking
Measured by fast Fourier transform (FFT) expressed in frequency (Hz) This outcome is valuable only for CoC arm and MoM arm, because Control arm patients don't wear prosthesis (no noise)
3 years
Amplitude of Articular Noise Produced During Level Walking
Measured by fast Fourier transform (FFT) expressed in amplitude (decibel) This outcome is valuable only for CoC arm and MoM arm, because Control arm patients don't wear prosthesis (no noise)
3 years
Secondary Outcomes (1)
Number of Participants Who Scored Positive for ALVAL
3 years
Study Arms (3)
Metal on Metal (MoM)
Patients wearing MoM hip prosthesis
Ceramic on Ceramic (CoC)
Patients wearing CoC hip prosthesis
Controls
Patients free from hip devices
Interventions
Dosage of Chromium and Cobalt on several biological matrices deriving from each patients. Determination of local/systemic reaction
Dosage of Vanadium and Titanium on several biological matrices deriving from each patients. Determination of range of noise
Dosage of Chromium, Cobalt, Vanadium and Titanium on several biological matrices deriving from each patients. Determination of local/systemic reaction
Eligibility Criteria
All the patients (no septic) afferent to our ward and wearing hip prosthesis MoM or CoC. A group of control patients, waiting for primary total hip arthroplasty.
You may qualify if:
- Patient waiting for primary total hip arthroplasty (THA)
- Patients MoM and CoC referring to our ward
- Informed consent approved
- Questionnaire on habits filled
You may not qualify if:
- Sepsis or suspected sepsis
- Patients exposed to other font of metals
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Laboratorio Tecnologia Medica
Bologna, Italy, 40136, Italy
Related Publications (4)
Beraudi A, Stea S, De Pasquale D, Bordini B, Catalani S, Apostoli P, Toni A. Metal ion release: also a concern for ceramic-on-ceramic couplings? Hip Int. 2014 Jul-Aug;24(4):321-6. doi: 10.5301/hipint.5000132. Epub 2014 Mar 24.
PMID: 24817392RESULTBeraudi A, Catalani S, Montesi M, Stea S, Sudanese A, Apostoli P, Toni A. Detection of cobalt in synovial fluid from metal-on-metal hip prosthesis: correlation with the ion haematic level. Biomarkers. 2013 Dec;18(8):699-705. doi: 10.3109/1354750X.2013.846413. Epub 2013 Oct 17.
PMID: 24134776RESULTCatalani S, Stea S, Beraudi A, Gilberti ME, Bordini B, Toni A, Apostoli P. Vanadium release in whole blood, serum and urine of patients implanted with a titanium alloy hip prosthesis. Clin Toxicol (Phila). 2013 Aug;51(7):550-6. doi: 10.3109/15563650.2013.818682. Epub 2013 Jul 11.
PMID: 23845123RESULTDe Pasquale D, Stea S, Beraudi A, Montesi M, Squarzoni S, Toni A. Ceramic debris in hip prosthesis: correlation between synovial fluid and joint capsule. J Arthroplasty. 2013 May;28(5):838-41. doi: 10.1016/j.arth.2013.01.019. Epub 2013 Mar 13.
PMID: 23489725RESULT
Biospecimen
Whole blood, serum, synovial fluid, urines, periprosthetic tissues, at -80°C
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Susanna Stea
- Organization
- Medical technology laboratory, Rizzoli Orthopaedic Institute
Study Officials
- STUDY DIRECTOR
Aldo Toni, MD
Istituto Ortopedico Rizzoli
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.sc.
Study Record Dates
First Submitted
February 19, 2015
First Posted
April 28, 2015
Study Start
August 1, 2012
Primary Completion
February 1, 2016
Study Completion
February 1, 2016
Last Updated
May 25, 2016
Results First Posted
May 25, 2016
Record last verified: 2016-04